预测和风险因素分层对肝细胞癌患者的生存:全国大数据分析
Jin Woo Choi1, Soohee Kang2, Juhee Lee2
1Department of Radiology, Seoul National University Hospital, Seoul National University, 101 Daehak-Ro, Jongno-Gu, Seoul, 03080, Republic of Korea.
Scientific reports
|June 27, 2023
概括
这项研究使用全国数据开发了一种新的肝细胞癌 (HCC) 预后系统. 瘤负担等级是预测HCC患者整体存活率 (OS) 的关键因素.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 在瘤学瘤学.
- 数据科学数据科学数据科学
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题.
- 准确的预后对于有效的HCC患者管理至关重要.
- 现有的预后模型可能无法完全捕捉HCC进展的复杂性.
研究的目的:
- 确定影响HCC患者整体存活时间 (OS) 的关键风险因素.
- 利用全国大数据开发和验证HCC的新型预后系统.
- 根据已识别的风险因素,将HCC患者分为不同的预后组.
主要方法:
- 对10573名成年HCC患者 (2008-2014) 全国数据库的分析.
- 开发使用导出队列 (6830名患者) 和条件推理树分析的预测系统.
- 系统的验证使用单独的医院队列 (4580名患者) 与C指数和校准图谱评估.
主要成果:
- 瘤负担 (TB) 级别成为HCC中OS最重要的预测因素.
- 在TB3 (TB1-3与TB4) 的切断线有效地分层了患者.
- 开发的系统创建了13个不同的预测组,具有很高的预测准确性 (C指数为0.714和0.737).
结论:
- 一个新的树结构预测系统准确地分层了HCC患者的预后.
- 该系统有效地可视化了影响整体生存的风险因素层.
- 该工具有助于详细评估患者的风险,并为HCC提供个性化的治疗策略.
更多相关视频
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.4K
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
8.3K
相关概念视频
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Comparing the Survival Analysis of Two or More Groups
228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Kaplan-Meier Approach
195
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
195
